Biotech Startups
9,920 companies tagged Biotech, with their investors and founders.
Synakis develops ocular biomaterials, including its lead candidate SNK-125, through pre-clinical research and a pipeline of eye-related products. The company operates in the ophthalmic biomaterial and biotech space.
2 investors
Syndeio Biosciences is a synapse-focused biotech developing precision neurotherapeutics for neuropsychiatric, mental health, and cognitive disorders such as depression and Alzheimer's. Its proprietary Boost Platform models synapse pharmacology, and its pipeline includes NMDA receptor positive allosteric modulators (zelquistinel and apimostinel) in Phase 2 clinical trials.
2 investors
2 investors
Synmedchem provides synthetic chemistry and medicinal chemistry services for drug discovery and compound design, serving pharmaceutical and biotech clients globally with teams across Australia, China, North America, the UK, and Europe.
2 investors
Synplogen is a synthetic biology startup spun out of Kobe University that offers custom artificial gene synthesis and DNA library construction services using its proprietary OGAB and Combinatorial-OGAB (Combi-OGAB) DNA assembly methods. It also operates a gene-therapy biofoundry that designs, develops, and analyzes gene-therapy products such as viral vectors, including CMC development work.
2 investors
Tacit Therapeutics develops RNA-based gene therapy approaches by redirecting cellular splicing processes to repair mutated genes. The company serves patients with genetic diseases and is based in San Francisco.
2 investors
Taconic Biosciences provides genetically engineered mouse and rat models, humanized immune system mice, custom model generation, colony management, and in vivo research services. It serves drug discovery and preclinical researchers, offering integrated laboratory animal models and services from model selection through study-ready cohorts.
2 investors
Talam Biotech develops natural, microbial-based products aimed at challenges in agriculture and food systems. The company focuses on turning scientific discovery into EPA-approved, commercially viable crop input solutions.
2 investors
Tamarind provides a computational platform for protein and molecular engineering, offering AI and physics-based tools to design antibodies, peptides, enzymes, and small molecules. The platform integrates state-of-the-art published tools like AlphaFold and RFdiffusion through a user-friendly interface for life sciences companies.
2 investors
Valo builds an AI-driven drug discovery and development platform that combines real-world human data, causal inference, statistical genetics, and predictive chemistry to identify disease targets and engineer small-molecule compounds. It applies closed-loop modeling and laboratory capabilities to advance lead compounds into drug candidates.
2 investors
Unlocking post-translational protein modification using chemical biology and computational approaches to develop drugs for previously undruggable oncology targets.
2 investors
Developing a scalable off-the-shelf allogeneic gamma delta T cell therapy platform.
2 investors
2 investors
TearSolutions develops Lacripep, a topical peptide therapy derived from the Lacritin protein for the treatment of dry eye disease, including cases associated with primary Sjögren's Syndrome. The company is running clinical trials of the drug candidate for patients with moderate to severe dry eye.
2 investors
Tectonic is a clinical-stage biotechnology company developing therapeutic proteins and antibodies that target G-Protein Coupled Receptors (GPCRs) using a proprietary platform called GEODe™. The company focuses on therapeutic areas with significant unmet medical needs where current treatment options are limited or absent.
2 investors
Teitur Trophics is a biotech company developing first-in-class cyclic peptides that target lysosomal, mitochondrial and pro-survival signaling pathways to preserve neuronal function. Its lead candidate, TT-P34, is a subcutaneous peptide in Phase I clinical development as a disease-modifying therapy for neurodegenerative diseases including Parkinson's, Huntington's disease and frontotemporal dementia.
2 investors
Telum Therapeutics develops antimicrobial drugs using synthetic biology and AI-driven machine learning, specializing in engineered lytic proteins to address multidrug-resistant infections. The company serves pharmaceutical and healthcare markets focused on treating infectious diseases with high unmet medical needs.
2 investors
Tenvie is a clinical-stage biopharmaceutical company developing small molecule and biologic therapeutics for neurological and peripheral diseases. The company is led by a team with expertise in biotech and precision medicine, targeting treatments for patients and caregivers affected by neurological conditions.
2 investors
Ternary develops AI-driven drug discovery technology focused on targeted protein degradation and induced proximity platforms. The company serves pharmaceutical and biotech organizations seeking computational approaches to identify novel therapeutic targets.
2 investors
Tesorai builds AI-powered data analysis software for life sciences researchers to extract insights from complex experimental datasets. The platform serves academic and biotech researchers who need to identify patterns and extract meaningful signals from massive datasets generated by high-throughput assays and other experiments.
2 investors
Teva Pharmaceuticals is a global pharmaceutical company that discovers, develops, and manufactures medicines to treat chronic conditions for patients across 57 markets. The company operates through approximately 37,000 employees focused on improving health outcomes and delivering quality treatments worldwide.
2 investors
The Akkermansia Company produces a consumer dietary supplement containing proprietary Akkermansia MucT™ bacteria formulated to support weight management, glucose metabolism, gut health, and immune function.
2 investors
Electrospinning is a materials technology company that manufactures electrospun products, with a focus on sustainable operations and rigorous safety standards for both patients and workers. The company serves customers across medical and industrial applications.
2 investors
EVERY produces animal-free egg white proteins using precision fermentation for use as functional ingredients in food and beverage applications. The company leverages fermentation technology to replicate the nutritional and functional properties of eggs at scale.
2 investors